ATLAS / Macro Radar / Reporting / XLO

Xilio Therapeutics, Inc. (XLO) reporting calendar

Xilio Therapeutics, Inc. files periodic reports with the SEC as XLO on Nasdaq. Atlas tracks 19 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
19

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open XLO market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001193125-26-218200
10-K31 Dec 202523 Mar 202682 days0001193125-26-118550
10-Q30 Sep 202513 Nov 202544 days0001193125-25-278837
10-Q30 Jun 202514 Aug 202545 days0001558370-25-011477
10-Q31 Mar 20258 May 202538 days0001558370-25-006996
10-K31 Dec 202411 Mar 202570 days0001558370-25-002640
10-Q30 Sep 20247 Nov 202438 days0001558370-24-014775
10-Q30 Jun 20248 Aug 202439 days0001558370-24-011471
10-Q31 Mar 202414 May 202444 days0001558370-24-008068
10-K31 Dec 20231 Apr 202492 days0001558370-24-004530
10-Q30 Sep 20239 Nov 202340 days0001558370-23-018587
10-Q30 Jun 202314 Aug 202345 days0001558370-23-014711
10-Q31 Mar 20239 May 202339 days0001558370-23-008676
10-K31 Dec 20222 Mar 202361 days0001558370-23-002687
10-Q30 Sep 20229 Nov 202240 days0001558370-22-017018
10-Q30 Jun 20229 Aug 202240 days0001558370-22-012756
10-Q31 Mar 202212 May 202242 days0001558370-22-008441
10-K31 Dec 20211 Mar 202260 days0001558370-22-002552
10-Q30 Sep 20212 Dec 202163 days0001558370-21-016476

Source: SEC EDGAR company submissions for CIK 0001840233. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.